Does DENOSUMAB Cause Therapy cessation? 211 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 211 reports of Therapy cessation have been filed in association with DENOSUMAB (Bilprevda). This represents 0.1% of all adverse event reports for DENOSUMAB.
211
Reports of Therapy cessation with DENOSUMAB
0.1%
of all DENOSUMAB reports
2
Deaths
47
Hospitalizations
How Dangerous Is Therapy cessation From DENOSUMAB?
Of the 211 reports, 2 (0.9%) resulted in death, 47 (22.3%) required hospitalization.
Is Therapy cessation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DENOSUMAB. However, 211 reports have been filed with the FAERS database.
What Other Side Effects Does DENOSUMAB Cause?
Off label use (34,612)
Death (16,545)
Osteonecrosis of jaw (8,438)
Arthralgia (5,890)
Pain in extremity (4,541)
Back pain (4,465)
Pain (4,102)
Product storage error (3,621)
Fall (3,322)
Fatigue (3,009)
What Other Drugs Cause Therapy cessation?
DALFAMPRIDINE (4,580)
ETANERCEPT (2,031)
ADALIMUMAB (1,712)
ABIRATERONE (1,602)
VOXELOTOR (1,038)
CLOZAPINE (885)
LOMITAPIDE (828)
CAPECITABINE (746)
TREPROSTINIL (743)
ISOTRETINOIN (633)
Which DENOSUMAB Alternatives Have Lower Therapy cessation Risk?
DENOSUMAB vs DEOXYCHOLIC ACID
DENOSUMAB vs DEPAKINE CHRONO
DENOSUMAB vs DEPAKOTE
DENOSUMAB vs DEPO-PROVERA
DENOSUMAB vs DERMATOPHAGOIDES FARINAE